Stock listing

Tokyo:4883 Modalis Therapeutics Corporation (モダリス) 株価

Follow Modalis Therapeutics Corporation into a list and get an email when it puts out news.

Modalis Therapeutics Corporation logo
Ticker
Tokyo:4883
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Tokyo
Currency
JPY

What changed lately

Latest news

Exegenesis Bio and Modalis Collaborate to Advance MDL-201 for Duchenne Muscular Dystrophy

Sep 10, 2026

(Correction) Regarding Corrections to the "Consolidated Financial Results for the Six Months Ended June 30, 2026 [Japanese GAAP]"

Aug 13, 2026

Business Plans and Matters Related to Growth Potential

Jul 14, 2026

Modalis Announces Publication in Human Gene Therapy of Study Demonstrating Efficient LAMA1 Gene Activation for the Treatment of LAMA2-CMD

Dec 24, 2025

Modalis has been selected as a finalist in the XPRIZE Healthspan FSHD Bonus Prize Competition and awarded research funds.

May 12, 2025

Modalis Therapeutics - MDL-101 for the Treatment of Congenital Muscular Dystrophy Type 1a has been granted Orphan Drug Designation in the US by the Food and Drug Administration

Oct 28, 2024

Modalis Therapeutics has received an Orphan Drug Designation from the U.S. Food and Drug Administration for MDL-101, a treatment for congenital muscular dystrophy type 1A (LAMA2-CMD).

Oct 25, 2024

Modalis Therapeutics: FDA Grants Rare Pediatric Disease Designation to MDL-101 for the Treatment of Congenital Muscular Dystrophy Type 1a (LAMA2-CMD)

Sep 30, 2024

Modalis Therapeutics Reports Data Supporting Development of a Transformative Epigenome Editing Therapeutic, MDL-101: a First-in-Class Epigenome Editing approach for the Treatment of LAMA2-deficient congenital muscular dystrophy (LAMA2-CMD)

May 7, 2024

Modalis Announces updated strategic plan and business consolidation of US operation

Apr 15, 2024

All Modalis Therapeutics Corporation news

Decks

Modalis Therapeutics Corporation on 6ix

Sector
Health care
Industry
Biotechnology
News releases
5 in the last 12 months · 20 in all · newest Sep 10, 2026 · oldest 2022
Decks
7 decks · latest Aug 14, 2026

Log in to ask 6ix AI your own questions about Modalis Therapeutics Corporation.